Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Cancers|June 2, 2021
Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors-A Strategy for Hematological Malignancies?Klara Klein, Dagmar Stoiber, Veronika Sexl, et al.
Frontiers in Immunology|July 22, 2022
The Multifaceted Role of STAT3 in NK-Cell Tumor SurveillanceAgnieszka Witalisz-Siepracka, Klara Klein, Bernhard Zdársky, et al.
Comparative Migration Studies|October 18, 2021
Organising labour market integration support for refugees in Austria and Sweden during the Covid-19 pandemicAlmina Bešić, Andreas Diedrich, Petra Aigner
International Journal of Cancer|August 14, 2019
JAK-STAT inhibition impairs K-RAS-driven lung adenocarcinoma progressionJulian Mohrherr, Marcel Haber, Kristina Breitenecker, et al.
Neoplasia (New York, N.Y.)|December 17, 2013
ETV6/RUNX1 induces reactive oxygen species and drives the accumulation of DNA damage in B cellsHans-Peter Kantner, Wolfgang Warsch, Alessio Delogu, et al.
Cancer Letters|January 26, 2025
Atovaquone and selinexor as a novel combination treatment option in acute myeloid leukemiaStefanie Weiss, Bernhard Zdársky, Agnieszka Witalisz-Siepracka, et al.
Blood|December 4, 2010
A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and developmentEva Eckelhart, Wolfgang Warsch, Eva Zebedin, et al.
Science Translational Medicine|June 22, 2018
Afatinib restrains K-RAS-driven lung tumorigenesisHerwig P Moll, Klemens Pranz, Monica Musteanu, et al.
Cancer Cell|July 18, 2006
STAT1 acts as a tumor promoter for leukemia developmentBoris Kovacic, Dagmar Stoiber, Richard Moriggl, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
The nature inspired peptide [T20K]-kalata B1 induces anti-tumor effects in anaplastic large cell lymphomaJudith Lind, Roland Hellinger, Petra Kudweis, et al.
Pageof 7